About Enhancer

Enhancer ID: E_02_0087
Species: human
Position : chr8:144311848-144313848
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: --
Pubmed ID:  29556394
Enhancer experiment: Proliferation study,Differentiation study,Differentiation study,Cytochemical staining
Enhancer experiment description: Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.

About Target gene

Target gene : DGAT1,FAS,CPT2
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.;Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.;Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.

About TF

TF name : --
TF experiment: Proliferation study,Differentiation study,Differentiation study,Cytochemical staining
TF experiment description: Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.;Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.;Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.

About Function

Enhancer function : Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
Treatment with BA modulated the expression of adipocytic differentiation markers: peroxisome proliferator-activated receptor ? and CCAAT/enhancer binding protein ? were significantly increased by both BA-2.5 and BA-5 throughout the study, while lipoprotein lipase and fatty acid-binding protein 4 were increased by BA-5 at day 3, and decreased by both BA-5 and BA- 2.5 later throughout the study.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs